Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Inositol 1,4,5-trisphosphate receptor interacting protein pseudogene (ENSG00000287779) is annotated as a pseudogene, meaning it is a genomic sequence similar to a protein-coding gene but is not believed to produce a functional protein product. Pseudogenes arise from duplication or retrotransposition events and typically harbor mutations that prevent gene expression or result in nonfunctional proteins. No data supports its function as a receptor, enzyme, transporter, or any therapeutic target, nor does it participate in known signaling pathways or disease processes. Accordingly, it is not considered a drug target or biomarker, and no safety or therapeutic concerns are associated with it.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inositol 1,4,5-trisphosphate receptor interacting protein pseudogene.